Genitourinary Cancer
Conference Coverage
TITAN: Final results confirm apalutamide benefit in mCSPC
Apalutamide reduced the risk of death by 35% overall and 48% when accounting for crossover.
Conference Coverage
CCR score can guide treatment decisions after radiation in prostate cancer
The score can identify patients with a low risk of metastasis who could potentially skip androgen deprivation therapy.
Conference Coverage
Liquid vs. tissue biopsy in advanced prostate cancer: Why not both?
Conference Coverage
Androgen annihilation strategy prolongs rPFS in mCRPC
Adding apalutamide to abiraterone and prednisone prolonged radiographic progression-free survival by 7.4 months.
Conference Coverage
Declines in PSA screening may account for rise in metastatic prostate cancers
Longitudinal reductions in PSA screening across U.S. states were associated with increased incidence of metastatic prostate cancer.
Conference Coverage
Combo disappoints in metastatic, castration-resistant prostate cancer
Adding saracatinib to docetaxel increased toxicity without improving efficacy.
From the Journals
MRI-guided prostate biopsy prevails in PRECISE trial
Conference Coverage
CXR-Net: An AI-based diagnostic tool for COVID-19
The tool showed promise in a pilot study.
Conference Coverage
Asymptomatic screening for COVID-19 in cancer patients still debated
Less than 1% of cancer patients studied were COVID-19 positive on asymptomatic screening.
Conference Coverage
Managing cancer outpatients during the pandemic: Tips from MSKCC
MSKCC has established guiding principles on how to manage cancer patients during the pandemic.
From the Journals
Aspirin linked to reduced bladder, breast cancer mortality
“The results presented here add to the accumulating evidence that aspirin may improve survival for some cancers.”